These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 8791974
21. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M. Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261 [Abstract] [Full Text] [Related]
22. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Youngberg CA, Berardi RR, Howatt WF, Hyneck ML, Amidon GL, Meyer JH, Dressman JB. Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103 [Abstract] [Full Text] [Related]
25. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW. Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747 [Abstract] [Full Text] [Related]
26. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis. Zentler-Munro PL, Assoufi BA, Balasubramanian K, Cornell S, Benoliel D, Northfield TC, Hodson ME. Pancreas; 1992 Oct; 7(3):311-9. PubMed ID: 1594552 [Abstract] [Full Text] [Related]
29. Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities. Pedersen PB, Vilmann P, Bar-Shalom D, Müllertz A, Baldursdottir S. Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):958-65. PubMed ID: 23727368 [Abstract] [Full Text] [Related]
30. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency. Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F. Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131 [Abstract] [Full Text] [Related]
31. [In vitro studies of pancreatic enzyme substitution]. Otte M, Ridder P, Dageförde J. Dtsch Med Wochenschr; 1987 Sep 25; 112(39):1498-502. PubMed ID: 2443331 [Abstract] [Full Text] [Related]
33. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency. Abrams CK, Hamosh M, Hubbard VS, Dutta SK, Hamosh P. J Clin Invest; 1984 Feb 25; 73(2):374-82. PubMed ID: 6699170 [Abstract] [Full Text] [Related]
35. A dynamic in vitro lipolysis model. II: Evaluation of the model. Zangenberg NH, Müllertz A, Kristensen HG, Hovgaard L. Eur J Pharm Sci; 2001 Oct 25; 14(3):237-44. PubMed ID: 11576829 [Abstract] [Full Text] [Related]
37. Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations. Whitehead AM. Pharm Weekbl Sci; 1988 Feb 19; 10(1):12-6. PubMed ID: 2451209 [Abstract] [Full Text] [Related]
39. Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis. Benito-Gallo P, Franceschetto A, Wong JC, Marlow M, Zann V, Scholes P, Gershkovich P. Eur J Pharm Biopharm; 2015 Jun 19; 93():353-62. PubMed ID: 25936853 [Abstract] [Full Text] [Related]
40. A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis. Calvo-Lerma J, Fornés-Ferrer V, Peinado I, Heredia A, Ribes-Koninckx C, Andrés A. PLoS One; 2019 Jun 19; 14(2):e0212459. PubMed ID: 30794618 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]